L-Lysine From the People's Republic of China: Initiation of Countervailing Duty Investigation

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Commerce International Trade Administration [C-570-216] ( printed page 26799) AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce. DATES: Applicable June 17, 2025. FOR FURTHER INFORMATION CONTACT: Allison Hollander, Office IX, AD/CVD Operations, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-2805. SUPPLEMENTARY INFORMATION: The Petition On May 28, 2025, the U.S. Department of Commerce (Commerce) received a countervailing duty (CVD) petition concerning imports of L-lysine (lysine) from the People's Republic of China (China), filed in proper form on behalf of the Lysine Fair Trade Coalition and its individual members (the petitioners). [ 1 ] The CVD Petition was accompanied by an antidumping duty (AD) petition concerning imports of lysine from China. [ 2 ] Between May 30 and June 12, 2025, Commerce requested supplemental information pertaining to certain aspects of the Petition in supplemental questionnaires. [ 3 ] Between June 2 and 16, 2025, the petitioners filed timely responses to these requests for additional information. [ 4 ] In accordance with section 702(b)(1) of the Tariff Act of 1930, as amended (the Act), the petitioners allege that the Government of China (GOC) is providing countervailable subsidies, within the meaning of sections 701 and 771(5) of the Act, to producers of lysine in China, and…